Download PDF
Semin Neurol 2009; 29(2): 124-135
DOI: 10.1055/s-0029-1213733
© Thieme Medical Publishers

Peripheral Nerve Complications of Medical Disease

Hannah R. Briemberg1
  • 1Department of Medicine, Division of Neurology, Neuromuscular Disorders Unit, University of British Columbia, Vancouver, British Columbia, Canada
Further Information

Publication History

Publication Date:
15 April 2009 (online)

    Permissions and Reprints

ABSTRACT

Neuropathies are associated with several systemic diseases. This article provides a general overview of the clinical presentation and management of the various neuropathies associated with common medical illnesses. The term “neuropathy” is used relatively broadly to encompass pathology from the level of the cell body to the terminal axon. Peripheral nerve disorders associated with diabetes, thyroid disease, connective tissue disease, cancer, and infection are discussed. The relationship between the various neuropathies and systemic illness is important to recognize because neuropathy may be the initial presentation of one of these underlying medical conditions. Alternatively, the presence of a known associated medical condition in a patient presenting with neuropathy may affect management decisions and limit unnecessary investigations.

KEYWORDS

Peripheral neuropathy - polyneuropathy - sensory ganglionopathy - vasculitis

REFERENCES

  • 1 Centers for Disease Control and Prevention .National Diabetes Surveillance System. Available at: http://www.cdc.gov/diabetes/statistics/index.htm Accessed August 20, 2008
    Google Scholar
  • 2 Singleton J R, Smith A G, Bromberg M B. Painful sensory polyneuropathy associated with impaired glucose tolerance.  Muscle Nerve. 2001;  24(9) 1225-1228
    CrossrefPubMedGoogle Scholar
  • 3 Martyn C N, Hughes R AC. Epidemiology of peripheral neuropathy.  J Neurol Neurosurg Psychiatry. 1997;  62 310-318
    CrossrefPubMedGoogle Scholar
  • 4 Winkler A S, Ejskjaer N, Edmonds M et al.. Dissociated sensory loss in diabetic autonomic neuropathy.  Diabet Med. 2000;  17(6) 457-462
    CrossrefPubMedGoogle Scholar
  • 5 Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy.  J Neurol Neurosurg Psychiatry. 1977;  40 1072-1082
    CrossrefPubMedGoogle Scholar
  • 6 The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus.  N Engl J Med. 1993;  329(14) 977-986
    Google Scholar
  • 7 Azad N, Emanuele N V, Abraira C et al.. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM).  J Diabetes Complications. 1999;  13(5–6) 307-313
    CrossrefPubMedGoogle Scholar
  • 8 Weber R B, Daroff R B, Mackey E A. Pathology of oculomotor nerve palsy in diabetics.  Neurology. 1970;  20 835-838
    CrossrefPubMedGoogle Scholar
  • 9 Al-Qattan M M, Manktelow R T, Bowen C V. Outcome of carpal tunnel release in diabetic patients.  J Hand Surg [Br]. 1994;  19(5) 626-629
    PubMedGoogle Scholar
  • 10 Chaudhuri K R, Wren D R, Werring D. Unilateral abdominal muscle herniation with pain: a distinctive variant of diabetic radiculopathy.  Diabet Med. 1997;  14(9) 803-807
    CrossrefPubMedGoogle Scholar
  • 11 Dyck P J, Norell J E, Dyck P J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.  Neurology. 1999;  53 2113-2121
    CrossrefPubMedGoogle Scholar
  • 12 Barohn R J, Sahenk Z, Warmolts J R, Mendell J R. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later.  Arch Neurol. 1991;  48(11) 1130-1135
    CrossrefPubMedGoogle Scholar
  • 13 Kelkar P, Masood M, Parry G J. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy).  Neurology. 2000;  55 83-88
    PubMedGoogle Scholar
  • 14 Llewelyn J G, Thomas P K, King R H. Epineurial microvasculitis in proximal diabetic neuropathy.  J Neurol. 1998;  245 159-165
    PubMedGoogle Scholar
  • 15 Kawagashira Y, Watanabe H, Oki Y et al.. Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy.  J Neurol Neurosurg Psychiatry. 2007;  78(8) 899-901
    CrossrefPubMedGoogle Scholar
  • 16 Ogawa T, Taguchi T, Tanaka Y, Ikeguchi K, Nakano I. Intravenous immunoglobulin therapy for diabetic amyotrophy.  Intern Med. 2001;  40(4) 349-352
    PubMedGoogle Scholar
  • 17 Krendel D A, Costigan D A, Hopkins L C. Successful treatment of neuropathies in patients with diabetes mellitus.  Arch Neurol. 1995;  52(11) 1053-1061
    PubMedGoogle Scholar
  • 18 Zochodne D W, Isaac D, Jones C. Failure of immunotherapy to prevent, arrest or reverse diabetic lumbosacral plexopathy.  Acta Neurol Scand. 2003;  107(4) 299-301
    CrossrefPubMedGoogle Scholar
  • 19 Kececi H, Degirmenci Y. Hormone replacement therapy in hypothyroidism and nerve conduction study.  Neurophysiol Clin. 2006;  36(2) 79-83
    CrossrefPubMedGoogle Scholar
  • 20 Van Dijk M A, Reitsma J B, Fischer J C, Sanders G T. Indications for requesting laboratory tests for concurrent diseases in patients with carpal tunnel syndrome: a systematic review.  Clin Chem. 2003;  49(9) 1437-1444
    CrossrefPubMedGoogle Scholar
  • 21 Beghi E, Delodovici M L, Bogliun G et al.. Hypothyroidism and polyneuropathy.  J Neurol Neurosurg Psychiatry. 1989;  52(12) 1420-1423
    CrossrefPubMedGoogle Scholar
  • 22 Nemni R, Bottacchi E, Fazio R et al.. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases.  J Neurol Neurosurg Psychiatry. 1987;  50(11) 1454-1460
    CrossrefPubMedGoogle Scholar
  • 23 Hawke S H, Davies L, Pamphlett R, Guo Y P, Pollard J D, McLeod J G. Vasculitic neuropathy. A clinical and pathological study.  Brain. 1991;  114 2175-2190
    CrossrefPubMedGoogle Scholar
  • 24 Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study.  Ann Neurol. 1988;  23 461-465
    CrossrefPubMedGoogle Scholar
  • 25 Kissel J T, Slivka A P, Warmolts J R, Mendell J R. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system.  Ann Neurol. 1985;  18 251-257
    CrossrefPubMedGoogle Scholar
  • 26 Moore P M, Richardson B. Neurology of the vasculitides and connective tissue diseases.  J Neurol Neurosurg Psychiatry. 1998;  65(1) 10-22
    CrossrefPubMedGoogle Scholar
  • 27 Ng K K, Yeung H M, Loo K T, Chan H M, Wong C K, Li P C. Acute fulminant neuropathy in a patient with Churg-Strauss syndrome.  Postgrad Med J. 1997;  73(858) 236-238
    CrossrefPubMedGoogle Scholar
  • 28 Terrier B, Lacroix C, Guillevin L et al.. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy.  Arthritis Rheum. 2007;  57(8) 1520-1529
    CrossrefPubMedGoogle Scholar
  • 29 Delalande S, de Seze J, Fauchais A L et al.. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.  Medicine (Baltimore). 2004;  83(5) 280-291
    CrossrefPubMedGoogle Scholar
  • 30 Mellgren S I, Conn D L, Stevens J C, Dyck P J. Peripheral neuropathy in primary Sjögren's syndrome.  Neurology. 1989;  39(3) 390-394
    PubMedGoogle Scholar
  • 31 Ramos-Casals M, Nardi N, Lagrutta M et al.. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.  Medicine (Baltimore). 2006;  85(2) 95-104
    CrossrefPubMedGoogle Scholar
  • 32 Moore P M. Vasculitic neuropathies.  J Neurol Neurosurg Psychiatry. 2000;  68(3) 271-274
    CrossrefPubMedGoogle Scholar
  • 33 Collins M P, Mendell J R, Periquet M I et al.. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy.  Neurology. 2000;  55(5) 636-643
    CrossrefPubMedGoogle Scholar
  • 34 Griffin J W, Cornblath D R, Alexander E et al.. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome.  Ann Neurol. 1990;  27(3) 304-315
    CrossrefPubMedGoogle Scholar
  • 35 Malinow K, Yannakakis G D, Glusman S M et al.. Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome.  Ann Neurol. 1986;  20(4) 535-537
    CrossrefPubMedGoogle Scholar
  • 36 Molina J A, Benito-Leon J, Bermejo F, Jiménez-Jiménez F J, Oliván J. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren's syndrome.  J Neurol Neurosurg Psychiatry. 1996;  60(6) 699
    PubMedGoogle Scholar
  • 37 Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome.  Neurology. 2003;  60 503-505
    PubMedGoogle Scholar
  • 38 Hagen N A, Stevens J C, Michet C J. Trigeminal sensory neuropathy associated with connective tissue diseases.  Neurology. 1990;  40 891-896
    PubMedGoogle Scholar
  • 39 Wasserstrom W R, Glass J P, Posner J B. Diagnosis and treatment of leptomeningeal metastasis from solid tumors: experience with 90 patients.  Cancer. 1982;  49 759-772
    CrossrefPubMedGoogle Scholar
  • 40 DeAngelis L M. Current diagnosis and treatment of leptomeningeal metastasis.  J Neurooncol. 1998;  38 245-252
    CrossrefPubMedGoogle Scholar
  • 41 Kori S H, Foley K M, Posner J B. Brachial plexus lesions in patients with cancer: 100 cases.  Neurology. 1981;  31 45-50
    PubMedGoogle Scholar
  • 42 Mullins G M, O'Sullivan S S, Neligan A et al.. Non-traumatic brachial plexopathies, clinical, radiological and neurophysiological findings from a tertiary centre.  Clin Neurol Neurosurg. 2007;  109(8) 661-666
    CrossrefPubMedGoogle Scholar
  • 43 Ahmad A, Barrington S, Maisey M, Rubens R D. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients.  Br J Cancer. 1999;  79(3–4) 478-482
    CrossrefPubMedGoogle Scholar
  • 44 Ampil F L. Radiotherapy for carcinomatous brachial plexopathy: a clinical study of 23 cases.  Cancer. 1985;  56 2185-2188
    CrossrefPubMedGoogle Scholar
  • 45 Jaeckle K A, Young D F, Foley K M. The natural history of lumbosacral plexopathy in cancer.  Neurology. 1985;  35 8-15
    PubMedGoogle Scholar
  • 46 Kelly J J, Kyle R A, Miles J M et al.. The spectrum of peripheral neuropathy in myeloma.  Neurology. 1981;  31 24-31
    PubMedGoogle Scholar
  • 47 Sumi S M, Farrell D F, Knauss T A. Lymphoma and leukemia manifested by steroid-responsive polyneuropathy.  Arch Neurol. 1983;  40 577-582
    PubMedGoogle Scholar
  • 48 Krendel D A, Stahl R L, Chan W C. Lymphomatous polyneuropathy. Biopsy of clinically involved nerve and successful treatment.  Arch Neurol. 1991;  48 330-332
    PubMedGoogle Scholar
  • 49 Kuwabara S, Misawa S, Kanai K et al.. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.  Neurology. 2008;  71 1691-1695
    CrossrefPubMedGoogle Scholar
  • 50 Chalk C H, Windebank A J, Kimmel D W, McManis P G. The distinctive clinical features of paraneoplastic sensory neuronopathy.  Can J Neurol Sci. 1992;  19 346-351
    PubMedGoogle Scholar
  • 51 Camdessanché J-P, Antoine J-C, Honnorat J et al.. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.  Brain. 2002;  125 166-175
    CrossrefPubMedGoogle Scholar
  • 52 Sagar H J, Read D J. Subacute sensory neuropathy with remission: an association with lymphoma.  J Neurol Neurosurg Psychiatry. 1982;  45 83-85
    CrossrefPubMedGoogle Scholar
  • 53 Gabriel C M, Gregson N A, Hughes R AC. Sensory neuropathy and anti-Hu antibodies in a patient with seminoma.  Eur J Neurol. 1996;  3 471-474
    PubMedGoogle Scholar
  • 54 Verschuuren J, Twijnstra A, De Baets M et al.. Hu antigens and anti-Hu antibodies in a patient with myxoid chondrosarcoma.  Neurology. 1994;  44 1551-1552
    PubMedGoogle Scholar
  • 55 Oh S J, Dropcho E J, Claussen G C. Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature.  Muscle Nerve. 1997;  20 1576-1582
    CrossrefPubMedGoogle Scholar
  • 56 Titulaer M J, Wirtz P W, Kuks J B et al.. The Lambert-Eaton myasthenic syndrome 1988: a clinical picture in 97 patients.  J Neuroimmunol. 2008;  201-202 153-158
    CrossrefPubMedGoogle Scholar
  • 57 O'Neill J H, Murray N M, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases.  Brain. 1988;  111 577-596
    PubMedGoogle Scholar
  • 58 Tim R W, Massey J M, Sanders D B. Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment.  Neurology. 2000;  54 2176-2178
    PubMedGoogle Scholar
  • 59 Lennon V A, Kryzer T J, Griesmann G E et al.. Calcium-channel antibodies in Lambert-Eaton and other paraneoplastic syndromes.  N Engl J Med. 1995;  332 1467-1474
    CrossrefPubMedGoogle Scholar
  • 60 Oguro-Okano M, Griesmann G E, Wieben E D, Slaymaker S J, Snutch T P, Lennon V A. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma.  Mayo Clin Proc. 1992;  67 1150-1159
    PubMedGoogle Scholar
  • 61 Jenkyn L R, Brooks P L, Forcier R J, Maurer L H, Ochoa J. Remission of Lambert-Eaton syndrome and small cell anaplastic carcinoma of the lung induced by chemotherapy and radiotherapy.  Cancer. 1980;  46 1123-1127
    CrossrefPubMedGoogle Scholar
  • 62 Newsom-Davis J. Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy.  Ann N Y Acad Sci. 1997;  835 111-119
    CrossrefPubMedGoogle Scholar
  • 63 Fathers E, Thrush D, Huson S M, Norman A. Radiation-induced brachial plexopathy in women treated for carcinoma of the breast.  Clin Rehabil. 2002;  16 160-165
    CrossrefPubMedGoogle Scholar
  • 64 Lederman R J, Wilbourn A J. Brachial plexopathy. Recurrent cancer or radiation?.  Neurology. 1984;  34 1331-1335
    PubMedGoogle Scholar
  • 65 Harper C M, Thomas J E, Cascino T L, Litchy W J. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG.  Neurology. 1989;  39 502-506
    PubMedGoogle Scholar
  • 66 Bowen J, Gregory R, Squier M, Donaghy M. The post-irradiation lower motor neuron syndrome: neuronopathy or radiculopathy?.  Brain. 1996;  119 1429-1439
    CrossrefPubMedGoogle Scholar
  • 67 Maier J G, Perry R H, Saylor W, Sulak M H. Radiation myelitis of the dorsolumbar spinal cord.  Radiology. 1969;  93 153-160
    PubMedGoogle Scholar
  • 68 Thomas J E, Cascino T L, Earle J D. Differential diagnosis between radiation and tumor plexopathy of the pelvis.  Neurology. 1985;  35 1-7
    PubMedGoogle Scholar
  • 69 Postma T J, Vermorken J B, Liefting A J, Pinedo H M, Heimans J J. Paclitaxel-induced neuropathy.  Ann Oncol. 1995;  6 489-494
    PubMedGoogle Scholar
  • 70 Chaudhry V, Cornblath D R, Corse A, Freimer M, Simmons-O'Brien E, Vogelsang G. Thalidomide-induced neuropathy.  Neurology. 2002;  59(12) 1872-1875
    CrossrefPubMedGoogle Scholar
  • 71 Richardson P G, Briemberg H, Jagannath S et al.. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.  J Clin Oncol. 2006;  24(19) 3113-3120
    CrossrefPubMedGoogle Scholar
  • 72 Roelofs R I, Hrushesky W, Rogin J, Rosenberg L. Peripheral sensory neuropathy and cisplatin chemotherapy.  Neurology. 1984;  34 934-938
    CrossrefPubMedGoogle Scholar
  • 73 Igarashi M, Thompson E, Rivera G K. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy).  Med Pediatr Oncol. 1995;  25 113-116
    CrossrefPubMedGoogle Scholar
  • 74 Mercuri E, Poulton J, Buck J et al.. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.  Arch Dis Child. 1999;  81 442-443
    CrossrefPubMedGoogle Scholar
  • 75 Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.  Br J Haematol. 2001;  115 323-325
    CrossrefPubMedGoogle Scholar
  • 76 Hildebrandt G, Holler E, Woenkhaus M et al.. Acute deterioration of Charcot-Marie-Tooth disease 1A (CMT 1A) following 2 mg of vincristine chemotherapy.  Ann Oncol. 2000;  11 743-747
    CrossrefPubMedGoogle Scholar
  • 77 Lacomis D, Petrella J T, Giuliani M J. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients.  Muscle Nerve. 1998;  21 610-617
    PubMedGoogle Scholar
  • 78 Zochodne D W, Bolton C F, Wells G A et al.. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.  Brain. 1987;  110 819-842
    CrossrefPubMedGoogle Scholar
  • 79 Gonzalez-Duarte A, Robinson-Papp J, Simpson D M. Diagnosis and management of HIV-associated neuropathy.  Neurol Clin. 2008;  26(3) 821-832
    CrossrefPubMedGoogle Scholar
  • 80 Cornblath D R, McArthur J C. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex.  Neurology. 1988;  38 794-796
    PubMedGoogle Scholar
  • 81 Simpson D M, Kitch D, Evans S R et al.. HIV neuropathy natural history cohort study: assessment measures and risk factors.  Neurology. 2006;  66 1679-1687
    CrossrefPubMedGoogle Scholar
  • 82 Morgello S, Estanislao L, Simpson D et al.. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy.  Arch Neurol. 2004;  61 546-551
    CrossrefPubMedGoogle Scholar
  • 83 Berger A R, Arezzo J, Schaumburg H et al.. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.  Neurology. 1993;  43 358-362
    PubMedGoogle Scholar
  • 84 Brannagan 3rd T H, Zhou Y. HIV-associated Guillain-Barré syndrome.  J Neurol Sci. 2003;  208(1–2) 39-42
    CrossrefPubMedGoogle Scholar
  • 85 Leger J M, Bouche P, Bolgert F et al.. The spectrum of polyneuropathies in patients infected with HIV.  J Neurol Neurosurg Psychiatry. 1989;  52(12) 1369-1374
    CrossrefPubMedGoogle Scholar
  • 86 Roullet E, Assuerus V, Gozlan J et al.. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases.  Neurology. 1994;  44 2174-2182
    CrossrefPubMedGoogle Scholar
  • 87 Miller R F, Fox J D, Thomas P et al.. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients.  J Neurol Neurosurg Psychiatry. 1996;  61(5) 456-460
    CrossrefPubMedGoogle Scholar
  • 88 Corral I, Quereda C, Casado J L et al.. Acute polyradiculopathies in HIV-infected patients.  J Neurol. 1997;  244(8) 499-504
    PubMedGoogle Scholar
  • 89 Sejvar J J, Bode A V, Marfin A A et al.. West Nile virus-associated flaccid paralysis.  Emerg Infect Dis. 2005;  11(7) 1021-1027
    CrossrefPubMedGoogle Scholar
  • 90 Leis A A, Stokic D S, Polk J L, Dostrow V, Winkelmann M. A poliomyelitis-like syndrome from West Nile virus infection.  N Engl J Med. 2002;  347 1279-1280
    CrossrefPubMedGoogle Scholar
  • 91 Glass J D, Samuels O, Rich M M. Poliomyelitis due to West Nile virus.  N Engl J Med. 2002;  347 1280-1281
    CrossrefPubMedGoogle Scholar
  • 92 Roos K L. Fever and asymmetrical weakness in the summer: evidence of a West Nile virus-associated poliomyelitis-like illness.  Mayo Clin Proc. 2003;  78(19) 1205-1206
    CrossrefPubMedGoogle Scholar
  • 93 Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K. Guillain-Barré syndrome: an usual presentation of West Nile virus infection.  Neurology. 2000;  55(1) 144-146
    PubMedGoogle Scholar
  • 94 Cepok S, Zhou D, Vogel F et al.. The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis.  Arch Neurol. 2003;  60(6) 849-855
    CrossrefPubMedGoogle Scholar
  • 95 Halperin J, Luft B J, Volkman D J, Dattwyler R J. Lyme neuroborreliosis. Peripheral nervous system manifestations.  Brain. 1990;  113(Pt 4) 1207-1221
    CrossrefPubMedGoogle Scholar
  • 96 Stanek G, Strle F. Lyme disease: European perspective.  Infect Dis Clin North Am. 2008;  22(2) 327-339
    CrossrefPubMedGoogle Scholar
  • 97 Kristoferitsch W, Sluga E, Graf M et al.. Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features.  Ann N Y Acad Sci. 1988;  539 35-45
    CrossrefPubMedGoogle Scholar
  • 98 Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease.  Eur J Neurol. 2006;  13(11) 1213-1215
    CrossrefPubMedGoogle Scholar
  • 99 Hemrika D J, Schutte M F, Bleker O P. Elsberg syndrome: a neurologic basis for acute urinary retention in patients with genital herpes.  Obstet Gynecol. 1986;  68(3, Suppl) 37S-39S
    PubMedGoogle Scholar
  • 100 Eberhardt O, Küker W, Dichgans J, Weller M. HSV-2 sacral radiculitis (Elsberg syndrome).  Neurology. 2004;  63(4) 758-759
    PubMedGoogle Scholar
  • 101 Haanpaa M, Hakkinen V, Nurmikko T. Motor involvement in acute herpes zoster.  Muscle Nerve. 1997;  20(11) 1433-1438
    CrossrefPubMedGoogle Scholar
  • 102 Greenberg M K, McVey A L, Hayes T. Segmental motor involvement in herpes zoster: an EMG study.  Neurology. 1992;  42(5) 1122-1123
    PubMedGoogle Scholar
  • 103 Dworkin R H, Johnson R W, Breuer J et al.. Recommendations for the management of herpes zoster.  Clin Infect Dis. 2007;  44(Suppl 1) S1-S26
    CrossrefPubMedGoogle Scholar
  • 104 Acharya J N, Pacheco V H. Neurologic complications of hepatitis C.  Neurologist. 2008;  14(3) 151-156
    CrossrefPubMedGoogle Scholar
  • 105 Tsukada N, Koh C S, Inoue A, Yanagisawa N. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen.  J Neurol Sci. 1987;  77(2–3) 203-216
    CrossrefPubMedGoogle Scholar
  • 106 Macleod W N. Sporadic non-A, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barré syndrome.  Arch Neurol. 1987;  44(4) 438-442
    PubMedGoogle Scholar
  • 107 De Klippel N, Hautekeete M L, De Keyser J, Ebinger G et al.. Guillain-Barré syndrome as the presenting manifestation of hepatitis C infection.  Neurology. 1993;  43(10) 2143
    PubMedGoogle Scholar
  • 108 Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections.  Clin Exp Rheumatol. 2006;  24(suppl 41) S71-S81
    PubMedGoogle Scholar

Hannah R BriembergM.D. F.R.C.P.C. 

Neuromuscular Disorders Unit

2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9

Email: hannah.briemberg@vch.ca

      >